{
  "content": "Diagnosis\n\t1. Rectal adenocarcinoma (mucinous type)\n\tDate of diagnosis\n\tJanuary 2023\n\n\tTreatment aim\n\tCurative\n\n\tSummary of completed treatment and relevant dates\n\n\tSurgery\n\t15 Aug 2023 Laparoscopic anterior resection\n\n\tRadiotherapy\n\t? Mar 2023 - ? Apr 2023\n\tLong-course chemoradiotherapy 50.4Gy in 28 fractions with concurrent capecitabine\n\n\tChemotherapy\n\t? Jan 2023 - ? Mar 2023\n\tNeoadjuvant CAPOX 3 cycles\n\n\tClinical studies\n\tNone\n\n\tCurrent disease status\n\tComplete pathological response\n\n\tCurrent issues\n\tMild anterior resection syndrome\n\n\tSummary of consultation\n\tI reviewed [redacted name] today for his end of treatment assessment. He has made an excellent recovery following completion of his multimodal treatment for locally advanced rectal cancer. The final histology showed complete pathological response (ypT0N0) to neoadjuvant therapy. He is managing well with diet modification for mild anterior resection syndrome. His bowel function continues to improve with 3-4 movements daily. He has returned to work full-time and has resumed regular exercise.\n\nOn examination today, his wound sites are well-healed. Digital rectal examination shows normal anastomosis with good tone. His latest CEA is normal at 2.1.\n\n\tFurther investigations\n\tCT chest/abdomen/pelvis booked for 3 months\n\tSurveillance colonoscopy to be arranged at 1 year\n\n\tMedication prescribed\n\tNone\n\n\tFollow up\n\tNext oncology follow up in 3 months with CT results\n\tSurgical follow up arranged with Mr [redacted name] in 6 weeks\n\n\tRequired GP actions\n\tRoutine health monitoring\n\n\tSummary of information given to patient\n\tDiscussed excellent treatment response and surveillance plan. Written information provided regarding managing anterior resection syndrome.",
  "output": {
    "primary_cancer": {
      "site": "rectum",
      "year": 2023,
      "month": 1,
      "metastases": "",
      "tnm_stage": "ypT0N0M0",
      "histopathology_status": "mucinous adenocarcinoma with complete pathological response to neoadjuvant therapy",
      "cancer_timeline": [
        {
          "type": "treatment_systemic_start",
          "value": "Started neoadjuvant CAPOX chemotherapy",
          "year": 2023,
          "month": 1
        },
        {
          "type": "treatment_radiotherapy",
          "value": "Completed long-course chemoradiotherapy 50.4Gy in 28 fractions with concurrent capecitabine",
          "year": 2023,
          "month": 4
        },
        {
          "type": "treatment_surgery",
          "value": "Laparoscopic anterior resection",
          "year": 2023,
          "month": 8
        },
        {
          "type": "laboratory_finding",
          "value": "CEA normal at 2.1",
          "year": 2024,
          "month": 1
        }
      ]
    },
    "patient_facts": [
      {
        "type": "current_symptom",
        "value": "Mild anterior resection syndrome with 3-4 bowel movements daily"
      },
      {
        "type": "examination_finding",
        "value": "Well-healed wound sites, normal anastomosis with good tone on digital rectal examination"
      },
      {
        "type": "quality_of_life_finding",
        "value": "Returned to work full-time and resumed regular exercise"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Locally advanced rectal cancer treated with multimodal therapy achieving complete pathological response. Excellent recovery with mild residual bowel symptoms."
      },
      {
        "type": "latest_treatment_response",
        "value": "Complete pathological response (ypT0N0) to neoadjuvant therapy"
      },
      {
        "type": "planned_investigation",
        "value": "CT chest/abdomen/pelvis in 3 months and surveillance colonoscopy at 1 year"
      },
      {
        "type": "follow_up_referral",
        "value": "Oncology follow up in 3 months with CT results, surgical follow up in 6 weeks"
      }
    ]
  }
}